Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Frontiers in Immunology
Christian Münz

Abstract

The human γ-herpesviruses Epstein-Barr virus (EBV or HHV4) and Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) are each associated with around 2% of all tumors in humans worldwide. However, investigations into their infection, oncogenesis, and immune responses that protect from the associated tumors have been hampered by the exclusive tropism of these pathogens for humans. Mice with reconstituted human immune system components (HIS mice) provide the unique opportunity to study persistent infection, virus associated lymphoma formation, and cell-mediated immune control of EBV and KSHV. Moreover, since these pathogens are unique stimuli for cytotoxic human lymphocyte responses, they also allow us to characterize long-lasting cell-mediated immune control and the requirements for its initiation, which would also be desirable to achieve during antitumor vaccination in general. Thus, human γ-herpesvirus infection of HIS mice provides unique insights into the biology of these important human pathogens and human cell-mediated immune responses that are considered to be the main protective entity against tumors.

References

Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·G Miller, M Lipman
Oct 13, 1998·Immunity·G J BabcockD A Thorley-Lawson
Mar 27, 2004·The New England Journal of Medicine·David A Thorley-Lawson, Andrew Gross
Dec 23, 2004·Journal of Virology·Lauri L Laichalk, David A Thorley-Lawson
Jan 13, 2006·International Journal of Cancer. Journal International Du Cancer·Donald Maxwell Parkin
Oct 24, 2006·Nature Medicine·Michael W MelkusJ Victor Garcia
Nov 28, 2007·Annual Review of Pathology·Don Ganem
Oct 11, 2008·The American Journal of Pathology·Mario CoccoLorenzo Leoncini
Apr 8, 2009·The Lancet Oncology·Véronique BouvardUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Jun 3, 2009·The Journal of Experimental Medicine·Till StrowigChristian Münz
Oct 17, 2009·The Journal of Infectious Diseases·Misako YajimaShigeyoshi Fujiwara
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Leonard D ShultzFumihiko Ishikawa
Sep 25, 2010·Nature Reviews. Cancer·Enrique A MesriChris Boshoff
Jan 20, 2012·Journal of Pediatric Hematology/oncology·Srdjan PasicIvana Lazarevic
Mar 13, 2012·The Journal of Clinical Investigation·Robert E WhiteMartin J Allday
Jul 20, 2013·European Journal of Haematology·Murat OzbalakBurhan Ferhanoglu
Oct 12, 2013·Annual Review of Pathology·Ethel Cesarman
Feb 12, 2014·Proceedings of the National Academy of Sciences of the United States of America·Lin-Xu WangCharles Wood
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Dec 9, 2014·The Journal of Clinical Investigation·Shi-Dong MaShannon C Kenney
Oct 2, 2015·Current Topics in Microbiology and Immunology·Jeffrey I Cohen
Oct 3, 2015·Current Topics in Microbiology and Immunology·Jennifer Kanakry, Richard Ambinder
Aug 30, 2016·The Journal of Clinical Investigation·Vanessa LandtwingChristian Münz
Nov 1, 2016·Journal of Virology·Lindsey M Hutt-Fletcher
Jan 22, 2017·The Journal of Experimental Medicine·Stuart G TangyeEmily S J Edwards

❮ Previous
Next ❯

Citations

Jan 28, 2020·The Journal of General Virology·Clara Lawler, Philip G Stevenson
Aug 27, 2019·Frontiers in Oncology·Claire Shannon-Lowe, Alan Rickinson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.